The Enduring Effects of Smoking in Latin America

Abstract

Objectives. We estimated smoking-attributable mortality, assessed the impact of past smoking on recent mortality, and computed expected future losses in life expectancy caused by past and current smoking behavior in Latin America and the Caribbean. Methods. We used a regression-based procedure to estimate smoking-attributable mortality and information for 6 countries (Argentina, Brazil, Chile, Cuba, Mexico, and Uruguay) for the years 1980 through 2009 contained in the Latin American Mortality Database (LAMBdA). These countries jointly comprise more than two thirds of the adult population in Latin America and the Caribbean and have the region’s highest rates of smoking prevalence. Results. During the last 10 years, the impact of smoking was equivalent to losses in male (aged ≥ 50 years) life expectancy of about 2 to 6 years. These effects are likely to increase, particularly for females, both in the study countries and in those that joined the epidemic at later dates. Conclusions. Unless innovations in the detection and treatment of chronic diseases are introduced soon, continued gains in adult survival in Latin America and the Caribbean region may slow down considerably.

Life expectancy with and without cognitive impairment among Chilean older adults: results of the National Survey of Health (2003, 2009 and 2016)

“…The increase in LE between 2003 and 2016 in Chile was lower than in Brazil [10] and the United States [23]. Mathers et al [24] have shown that mortality rates in old age in middle and high income countries, including Chile, have been consistently decreasing. Others have suggested that increases in LE at 50 years of age in Latin America are slowing, attributable to the impact of smoking [25].…”

SES Gradients Among Mexicans in the United States and in Mexico: A New Twist to the Hispanic Paradox?

“…Smoking prevalence is lower in Mexico than in the United States (Palloni et al 2015) and appears to account for part of the adult HHP at older ages in the United States (Blue and Fenelon 2011). However, little is known about smoking-SES gradients among MFB in the United States (see Buttenheim et al 2010; Riosmena and Dennis 2012).…”

Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela

“…In Latin America, its use has markedly increased since 1950, and is now considered the second most common cardiovascular risk factor, following high blood pressure 30 . This has led to an increase in cancer deaths and a drop in life expectation of 2–6 years 31 . In Maracaibo, high prevalence of cigarette smoking and MS has been observed, which may suggest an existing relationship between these variables 6, 32 .…”